Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
Mariapaola Izzo, Jonathan Battistini, Claudia Provenzano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4622-4622
Open Access | Times Cited: 24

Showing 24 citing articles:

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1
Mariapaola Izzo, Jonathan Battistini, Elisabetta Golini, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Non-canonical DNA structures: Diversity and disease association
Aparna Bansal, Shikha Kaushik, Shrikant Kukreti
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 52
The myotonic dystrophy type 1 drug development pipeline: 2022 edition
Marta Pascual-Gilabert, Rubén Artero, Arturo López Castel
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103489-103489
Open Access | Times Cited: 37
Identification of a CCG-Enriched Expanded Allele in Patients with Myotonic Dystrophy Type 1 Using Amplification-Free Long-Read Sequencing
Yu‐Chih Tsai, Laure de Pontual, Cheryl Heiner, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 11, pp. 1143-1154
Open Access | Times Cited: 17
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
Lubov Timchenko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10491-10491
Open Access | Times Cited: 17
Influence of CTG repeats from the human DM1 locus on murine gut microbiota
Manijeh Mahdavi, Kim Taeyeon, Karine Prévost, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 733-743
Open Access
Treatments and therapies for symptoms and clinical manifestations of adult type 1 myotonic dystrophy: A scoping review
A. Childs, Robert D. Henderson, Daniel James Henderson, et al.
Journal of the Neurological Sciences (2025) Vol. 472, pp. 123470-123470
Open Access
Bruno 1/CELF regulates splicing and cytoskeleton dynamics to ensure correct sarcomere assembly in Drosophila flight muscles
Elena Nikonova, Jenna DeCata, Marc Canela, et al.
PLoS Biology (2024) Vol. 22, Iss. 4, pp. e3002575-e3002575
Open Access | Times Cited: 3
Molecular mechanisms and therapeutic strategies for neuromuscular diseases
Alberto A. Zambon, Falzone Yuri Matteo, Bolino Alessandra, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy
Subodh Kumar Mishra, Sawyer M Hicks, Jesús Frías, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Associations between lower extremity muscle fat fraction and motor performance in myotonic dystrophy type 2: A pilot study
Diana Madrid, Rebecca A. Knapp, Delanie Lynch, et al.
Muscle & Nerve (2023) Vol. 67, Iss. 6, pp. 506-514
Open Access | Times Cited: 3
Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy
Zuzanna Rogalska, Krzysztof Sobczak
Molecular Therapy — Nucleic Acids (2022) Vol. 30, pp. 438-448
Open Access | Times Cited: 4
Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines
Camila de Almeida, Florence Robriquet, Tatyana A. Vetter, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
TALEN-induced contraction of CTG trinucleotide repeats in myotonic dystrophy type 1 cells
Laureline Bétemps, Stéphane Descorps‐Declère, Olivia Frenoy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Massive contractions of myotonic dystrophy type 2-associated CCTG tetranucleotide repeats occur via double-strand break repair with distinct requirements for DNA helicases
David Papp, Luis C. Hernandez, Theresa Asen, et al.
G3 Genes Genomes Genetics (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Brain Diseases Associated with Unstable Repeats
Katharine E. Shelly, Emily G. Allen, Peng Jin
Oxford University Press eBooks (2024), pp. 228-251
Closed Access
Muscle Involvement and Restricted Disorders
Basil T. Darras, Joseph J. Volpe
Elsevier eBooks (2024), pp. 1074-1121.e18
Closed Access
Examples of diseases where appropriate therapies were discovered
Moyra Smith
Elsevier eBooks (2024), pp. 209-262
Closed Access
Designing therapies relevant in human genetic disorders
Moyra Smith
Elsevier eBooks (2024), pp. 355-406
Closed Access
Cure the Incurable: Update of Treatment in Inherited Neuromuscular Disorders
Cheng-Hao Yu, Kuan-Lin Lai
Acta Neurologica Taiwanica (2024) Vol. 33, Iss. 4, pp. 129-135
Closed Access
Bruno 1 regulates cytoskeleton dynamics and a temporal splicing transition to promote myofibril assembly, growth and maturation inDrosophilaflight muscle
Elena Nikonova, Marc Canela Grimau, Christiane Barz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Massive contractions of Myotonic Dystrophy Type 2-associated CCTG tetranucleotide repeats occur via double strand break repair with distinct requirements for helicases
David Papp, Luis Hernández, Theresa Asen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Cranial Nerves and Myopathies
Kristl G. Claeys
Springer eBooks (2023), pp. 195-201
Closed Access
Myotonic Dystrophy Type 1: A Comprehensive Literary Review
Aditya Tripathi, Alex Miliken
Journal of Student Research (2023) Vol. 12, Iss. 4
Open Access
Page 1

Scroll to top